Strategic Global Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-7,708
| Closed | -$2.71M | – | 170 |
|
|
2023
Q2 | $2.71M | Sell |
7,708
-450
| -6% | -$158K | 0.42% | 79 |
|
|
2023
Q1 | $2.57M | Sell |
8,158
-677
| -8% | -$213K | 0.41% | 79 |
|
|
2022
Q4 | $2.55M | Sell |
8,835
-141
| -2% | -$40.7K | 0.41% | 83 |
|
|
2022
Q3 | $2.6M | Sell |
8,976
-253
| -3% | -$73.3K | 0.43% | 79 |
|
|
2022
Q2 | $2.6M | Buy |
9,229
+990
| +12% | +$279K | 0.4% | 86 |
|
|
2022
Q1 | $2.15M | Buy |
8,239
+292
| +4% | +$76.2K | 0.31% | 90 |
|
|
2021
Q4 | $1.75M | Buy |
7,947
+622
| +8% | +$137K | 0.23% | 108 |
|
|
2021
Q3 | $1.33M | Buy |
7,325
+1,532
| +26% | +$278K | 0.19% | 117 |
|
|
2021
Q2 | $1.17M | Sell |
5,793
-633
| -10% | -$128K | 0.21% | 125 |
|
|
2021
Q1 | $1.38M | Sell |
6,426
-361
| -5% | -$77.6K | 0.25% | 113 |
|
|
2020
Q4 | $1.6M | Sell |
6,787
-157
| -2% | -$37.1K | 0.28% | 104 |
|
|
2020
Q3 | $1.89M | Buy |
6,944
+2,512
| +57% | +$684K | 0.36% | 77 |
|
|
2020
Q2 | $1.29M | Buy |
4,432
+1,192
| +37% | +$346K | 0.28% | 95 |
|
|
2020
Q1 | $771K | Buy |
+3,240
| New | +$771K | 0.2% | 102 |
|